QWM
IONS icon

Quaker Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Quaker Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19K Hold
15
– – ﹤0.01% 543
2026
Q1 		$1.13K Buy
15
+1
+7% +$79 ﹤0.01% 508
2025
Q4 		$1.11K Hold
14
– – ﹤0.01% 520
2025
Q3 		$916 Hold
14
– – ﹤0.01% 483
2025
Q2 		$554 Buy
+14
New +$458 ﹤0.01% 589

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
WMA
West Michigan Advisors Holland, Michigan $455M AUM 31.82% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Quaker Wealth Management's IONS Position: Q2 2026 in Review

Quaker Wealth Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 15 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #543.

Quaker Wealth Management first reported a position in IONS in Q2 2025 and has held it in 5 quarters since. 84 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Quaker Wealth Management held 15 shares of Ionis Pharmaceuticals worth $1.19K as of Q2 2026.
  • Quaker Wealth Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #543 holding.
  • Quaker Wealth Management first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 84 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.